We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 38.50 | 38.00 | 40.00 | - | 0.00 | 07:30:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 93.90 | 48.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/11/2016 14:21 | Isn't there a Daily Mail tip influence with VANL, dacian? About time I was right about something, red! Right approach with TRCS in my opinion, PJ1. But I would wait for the news before entering. Too many long-term holders bailed out and the latest FY read exactly like a year old. Paul Scott said he would be soliciting for questions with his annual interview with the CEO today - but it has all gone quiet. apad | apad | |
23/11/2016 13:51 | dacian Thanks. I have broad shoulders. red | redartbmud | |
23/11/2016 09:33 | dacian Good call. I think that you are on the right lines. I started my due diligence but had to go out before I finished. The share price then started to move before I got back into it. Just shows that instinct can be a valuable tool - or not in some cases. red | redartbmud | |
23/11/2016 09:32 | TRCS- Its hard to tell if the chart is rolling over or consolidating. A nice long consolidation would be nice for a re-entry (coupled with news ) | pj 1 | |
23/11/2016 08:53 | APAD Your call on Ror was right. red | redartbmud | |
23/11/2016 07:59 | Thanks - thin finger? red | redartbmud | |
22/11/2016 21:40 | edited :-) apad | apad | |
22/11/2016 21:35 | At £7 I might be bottom fishing for Gsk. red | redartbmud | |
22/11/2016 21:24 | I think the TRCS story has changed. So, it's more of a reduction policy, red. GSK still on the top-slice agenda, but over £17 :-) apad | apad | |
22/11/2016 20:30 | APAD I thought that you had resolved not to top slice in future. Was I mistaken? red | redartbmud | |
22/11/2016 20:09 | ps My 8k XMAS forecast for the FTSE looks more than a little unlikely. However,this level seems to be artificially depressed. | apad | |
22/11/2016 20:04 | 225 floor on ROR I reckon. More oil and dollar strength on the way. Company specific worries gone away. Bifold inspires zero confidence. HLMA, typical conservative reporting (without too much currency tailwind emphasis) should inspire some weakness. Some ludicrous actuarial pension comments for the wary. Nothing at all worrying. Worth watching for dips. Should've top-sliced TRCS more. apad | apad | |
22/11/2016 17:36 | Agreed, Ror has fallen more than most, and that was my first thought, when I was disposed not to sell. Having given much thought, a significant amount of the profit is coming from currency for the current year viz: Outlook The trading environment is anticipated to remain challenging across most of our key markets and geographies. Margins are expected to be lower than the prior year, as previously indicated, but in line with market expectations. Currency continues to provide a tailwind, and based on current exchange rates is now expected to deliver a 10% benefit to both full year revenue and profit. It was the margins wot done it guv, coupled with the indigestion at Bifold. Buying back around £2 would be a nice little deal that might just happen when Opec et al fall out again. I don't see them at £2,50 in the short term. Time will tell if I am right, and there may be some sellers in the morning. 13% gain on the results is a big call. red | redartbmud | |
22/11/2016 17:14 | ps Also ROR has fallen more than most. | apad | |
22/11/2016 17:11 | Probably sensible. I decided to bet the OPEC talks lifting the boats. apad | apad | |
22/11/2016 16:27 | Top sliced Ror @226.9p Hedging my bets. red | redartbmud | |
22/11/2016 13:55 | APAD Graham Ogden, who retired on 31v March 2015. Had his finger on the pulse. red | redartbmud | |
22/11/2016 13:50 | Foot, self - shot in - not in selling Ror on the bounce. Missed 230p but had 227p on the screen. Hey ho, diddly do. red | redartbmud | |
22/11/2016 11:14 | Who was that, red? There was Henderson, an accountant? apad | apad | |
22/11/2016 10:18 | APAD The retirement of his predecessor is a body blow to Ror. He will not be replaed in the short term. red | redartbmud | |
22/11/2016 09:57 | ROR board makes good reading .... ...except for this: Gary joined Rotork in September 2015 as General Manager of the Bifold Group, a role he retains as well as the position of Group Innovation Director. Innovative design engineering has been a major area of activity in his career, where he has gained a wealth of experience and knowledge of products and markets relevant to Rotork. Appointed to the Board 2015 ! apad | apad | |
22/11/2016 09:15 | Bifold timing was dreadful for ROR - it's O&G innit. Good to see "tailwinds" :-) Trying to disentangle the OCC stuff - might give up. Current oil price vibes should lift all boats. The breadth of ROR is making it difficult for me. At one level it creates diversity and insulates from the worst of the O&G shock. At another level it takes away a distinct identity and I am uncomfortable with serial acquisitions. I'm running it with the sector for a while, but may top-slice if this uncomfortable feeling doesn't go away. Market surprised by ROR, but not by HLMA/SPX. apad | apad |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions